.... This study aimed to investigate the specific requirements of middle-aged and older patients with chronic kidney disease (CKD) for self-management through mobile health applications (mHealth apps), using the Kano model. Methods: A multicenter cross-sectional survey was conducted from April to September 2023...

... the chronic kidney disease (CKD) patient population of a large teaching hospital, with a population breakdown largely similar to that of England as a whole. Methods: We compared four estimating equations (Modification of Diet in Renal Disease [MDRD], CKD-EPI [2009], CKD-EPI [2021], and European Kidney...

... sodium concentration at baseline (<135 or >146 mmol/L); age <18 years; diabetes mellitus; decompensated liver disease; heart failure; and stage 5 chronic kidney disease. Results: After adjustment for known risk factors, there was a significant “U-shaped” relationship between serum sodium...

...Indradip Maity; Hemchand Sati; Geetika Singh; Dipankar Bhowmik; Sanjay Kumar Agarwal; Soumita Bagchi Introduction: Chronic kidney disease of undetermined aetiology (CKDu) is an important public health problem. Indian data are mostly based on studies from rural regions in south and east India. We...

...Wanting Weng; Siow-Yi Wong; Gary Yee Ang; Sheryl Hui Xian Ng; Chee Kong Lim; See Cheng Yeo Background: Accurate identification of individuals at risk of developing chronic kidney disease (CKD) may improve clinical care. Nelson et al. developed prediction equations to estimate the risk of incident...

...Yoshitaka Miyaoka; Takahito Moriyama; Suguru Saito; Sho Rinno; Miho Kato; Ryuji Tsujimoto; Rie Suzuki; Rieko China; Miho Nagai; Yoshihiko Kanno Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2Is) have beneficial effects on the renal function of chronic kidney disease (CKD) patients...

... apical and basolateral BA transporters. Furthermore, we explore changes in BAs and their potential implications for various renal diseases, particularly chronic kidney disease. Lastly, we center our discussion on FXR, a key BA receptor in the kidney and a potential therapeutic target for renal diseases...

... Christensen; Louise S. Dalbøge Introduction: Several mouse models with diverse disease etiologies are used in preclinical research for chronic kidney disease (CKD). Here, we performed a head-to-head comparison of renal transcriptome signatures in standard mouse models of CKD to assess shared and distinct...

... was to explore the association between urate-lowering agents and reduced response to erythropoietin-stimulating agents in patients suffering from chronic kidney disease G5. Methods: We conducted a cross-sectional, multicenter study in Japan between April and June 2013, enrolling patients aged 20 years or older...

...Paolo Lopedote; Juliano Alhaddad; Guoliang Zheng; Mu’taz Abualshar; Shree Ghanta; Olga Kozyreva; Bertrand L. Jaber Introduction: Multiple myeloma (MM) frequently involves the kidneys, resulting in acute, subacute, or chronic kidney disease (CKD). Patient- and treatment-related factors...

... and symptoms during hemodialysis seem to contribute to post-dialysis fatigue and a longer post-dialysis recovery time [ 9, 10 ]. Self-reported fatigue, ranging from tiredness to exhaustion is highly prevalent in patients with chronic kidney disease, especially in those undergoing maintenance hemodialysis...

...Alexander L. Bullen; Sucheta Vaingankar; Magdalena Madero; Salvador Lopez Gil; Etienne Macedo; Joachim H. Ix; Dena E. Rifkin; Pranav S. Garimella Background: Interstitial fibrosis and tubular atrophy (IFTA) are common findings on biopsy in chronic kidney disease (CKD) and are strongly predictive...

...Zhipeng Yan; Tingting Shao Background: Chronic kidney disease (CKD) is an increasingly prevalent disease that affects approximately 10–12% of the global population. Therefore, it is considered a public health priority. Persistent and systemic low-grade chronic inflammation (CI) is an important part...

...Guldehan Haberal; Tolga Yildirim; Seref Rahmi Yilmaz; Bulent Altun; Fazil Tuncay Aki; Yunus Erdem; Mustafa Arici Background: Living kidney donors (LKD) may experience some untoward consequences following donation such as development of chronic kidney disease (CKD). In this study, we aimed...

...Graeme Smith; Siu-Fai Lui; Kamyar Kalantar-Zadeh; Ann Bonner Background: As a social determinant of health, health literacy has a vital role in the management of chronic disease management, including chronic kidney disease (CKD). Summary: To be able to manage their condition, patients with CKD need...

...Meike Ying; Xue Shao; Hongli Qin; Pei Yin; Yushi Lin; Jie Wu; Jingjing Ren; Yang Zheng Background: Chronic kidney disease (CKD) is a serious public health issue worldwide, but the disease burden of CKD caused by different etiologies and changing trends has not been fully examined. Methods: We...

...Michał Nowicki; Maciej Drożdż; Jarosław Wajda; Wiesław Klatko; Agnieszka Segiet-Święcicka Background: Renal anemia is one of the most common complications of chronic kidney disease (CKD). This real-life study assessed the effectiveness of methoxy polyethylene glycol-epoetin beta, a continuous...

...Zihao Zhang; Peipei Liu; Ling Yang; Naihui Zhao; Wenli Ou; Xiaofu Zhang; Yinggen Zhang; Shuohua Chen; Shouling Wu; Xiuhong Yang Introduction: Inflammation is associated with development of chronic kidney disease (CKD). However, the association of the high-sensitivity C-reactive protein (hs-CRP...

...Raúl Morales Febles; Domingo Marrero Miranda; Coriolano de la Concepción Cruz Perera; Laura Díaz Martín; Ana Elena Rodríguez-Rodríguez; Amelia Remedios González Martín; Daniel Javier Sánchez Báez; Esteban Porrini Background: Chronic kidney disease (CKD) affects 11–13% of the world population...

...), and particularly liver fibrosis, has been suggested as a risk factor of chronic kidney disease (CKD). Given that NAFLD affects every fourth person globally, better insight is needed. Our aim was to investigate the association between hepatic fibrosis and CKD in patients with type 2 diabetes and to compare...